Product Information
INVOKANA 100 MG TABLET is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $19.1040 per EA under NDC 50458014090. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
100 mg/1
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458014090
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CANAGLIFLOZINApproval Type
New Drug (NDA)
FDA Application
NDA204042On Market Since
3/29/2013
Pharmacological Classes
Price Statistics
The NADAC for INVOKANA 100 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 124.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.1040 per EA |
|---|---|
| All-time high | $19.1811 (Sep 11, 2024) |
| All-time low | $8.5018 (Nov 28, 2013) |
| 52-week high | $19.1479 |
| 52-week low | $19.0997 |
| Median price | $16.5747 |
| Average price | $15.6457 |
| Largest weekly change | +9.9% (Jan 15, 2014) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of INVOKANA 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for INVOKANA 100 MG TABLET, manufactured by Janssen Pharmaceuticals Inc., is $19.1040 per EA (NDC 50458014090), effective Jun 24, 2026.
How has the price of INVOKANA 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for INVOKANA 100 MG TABLET has risen 124.7%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for INVOKANA 100 MG TABLET?
Since Nov 28, 2013, the NADAC for INVOKANA 100 MG TABLET has ranged from a low of $8.5018 (Nov 28, 2013) to a high of $19.1811 (Sep 11, 2024), with a median of $16.5747 per EA.
Are there cheaper alternatives to INVOKANA 100 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as INVOKANA 100 MG TABLET, but none are currently priced below it.
Who manufactures INVOKANA 100 MG TABLET?
INVOKANA 100 MG TABLET (NDC 50458014090) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification